3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uveal Melanoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Lung Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Adenoma, Islet Cell
1
Interventions
Temozolomide
9
Radiotherapy
7
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Vincristine
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Procarbazine
2
Lomustine
2
vorasidenib
1
vocimagene amiretrorepvec
1
trametinib
1
pemigatinib
1
pembrolizumab
1
olutasidenib
1
mirdametinib
1
fluorodopa F 18
1
dabrafenib
1
abexinostat
1
abemaciclib
1
Vorinostat
1
Tretinoin
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Conformal
1
Protons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
aflibercept
×
1 year
×
Clear all
No trials found.